bridgebio shares phase 2 data for infigratinib in achondroplasia
BridgeBio(BBIO)2023-03-06 18:03
PROPEL2 topline results Forward-looking statements This presentation contains forward-looking statements. Statements in this presentation may include statements that are not historical facts and are considered forward- looking within the meaning of Section 27A of the Securities Act of 1933, as amended (the Securities Act), and Section 21E of theSecurities Exchange Act of 1934, as amended (the Exchange Act), which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “exp ...